ナチュラルキラー細胞療法の世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

当レポートは、ナチュラルキラー細胞療法 (Natural Killer Cell Therapy) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 市場：タイプ別
  • 世界のタイプ別市場成長: 2020 VS 2024 VS 2031
  • NK Cell Therapy
  • CAR-NK Cell Therapy
• 市場：用途別
  • 世界の用途別市場シェア: 2020 VS 2024 VS 2031
  • Cancer
  • Infectious Diseases
  • Gastrointestinal Diseases
  • Beauty and Anti-Aging
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 世界の市場成長トレンド

• 世界のナチュラルキラー細胞療法の市場展望 (2020-2031)
• 世界の市場規模：地域別: 2020 VS 2024 VS 2031
• 世界のナチュラルキラー細胞療法の収益市場シェア 地域別 (2020-2025)
• 世界のナチュラルキラー細胞療法の収益予測：地域別 (2026-2031)
• 主要地域と新興市場分析
  • 北米のナチュラルキラー細胞療法 市場規模および予測 (2020-2031)
  • 欧州のナチュラルキラー細胞療法 市場規模および予測 (2020-2031)
  • 中国のナチュラルキラー細胞療法 市場規模および予測 (2020-2031)
  • 日本のナチュラルキラー細胞療法 市場規模および予測 (2020-2031)

第3章 内訳データ：タイプ別

• 世界のナチュラルキラー細胞療法の市場規模実績：タイプ別 (2020-2025)
• 世界のナチュラルキラー細胞療法の市場規模予測：タイプ別 (2026-2031)
• 各種タイプ ナチュラルキラー細胞療法 代表的な企業

第4章 内訳データ：用途別

• 世界のナチュラルキラー細胞療法の市場規模実績：用途別 (2020-2025)
• 世界のナチュラルキラー細胞療法の市場規模予測：用途別 (2026-2031)
• 新たな成長源 ナチュラルキラー細胞療法 アプリケーション

第5章 競合他社の状況

• 世界トップ企業 収益
  • 世界のナチュラルキラー細胞療法の上位企業：収益別 (2020-2025)
  • 世界のナチュラルキラー細胞療法の収益シェア：企業別 (2020-2025)
• 世界の企業タイプ別市場シェア (Tier 1, Tier 2, and Tier 3)
• 企業ランキング： ナチュラルキラー細胞療法 収益
• 世界のナチュラルキラー細胞療法 市場集中度分析
  • 世界のナチュラルキラー細胞療法 市場集中度 (CR5 and HHI)
  • 世界の上位10・上位5企業： ナチュラルキラー細胞療法 収益 2024年
• 世界の主要企業 ナチュラルキラー細胞療法 本社 および提供地域
• 世界の主要企業 ナチュラルキラー細胞療法, 製品およびアプリケーション
• 世界の主要企業 ナチュラルキラー細胞療法, 業界参入時期
• M&A, 拡張計画

第6章 地域分析

• 北米の市場: Pレイヤー, セグメントs and 下流
  • 北米のナチュラルキラー細胞療法 企業別収益 (2020-2025)
  • 北米の市場規模：タイプ別
  • 北米の市場規模：用途別
  • 北米の市場 トレンドと機会
• 欧州の市場: Pレイヤー, セグメントs and 下流
  • 欧州のナチュラルキラー細胞療法 企業別収益 (2020-2025)
  • 欧州の市場規模：タイプ別
  • 欧州の市場規模：用途別
  • 欧州の市場 トレンドと機会
• 中国の市場: Pレイヤー, セグメントs and 下流
  • 中国のナチュラルキラー細胞療法 企業別収益 (2020-2025)
  • 中国の市場規模：タイプ別
  • 中国の市場規模：用途別
  • 中国の市場 トレンドと機会
• 日本の市場: Pレイヤー, セグメントs and 下流
  • 日本のナチュラルキラー細胞療法 企業別収益 (2020-2025)
  • 日本の市場規模：タイプ別
  • 日本の市場規模：用途別
  • 日本の市場 トレンドと機会

第7章 主要企業のプロファイル

• Nektar Therapeutics
• ImmunityBio, Inc
• GC Cell
• Affimed
• Innate Pharma SA
• Fate Therapeutics
• Glycostem Therapeutics
• Dragonfly Therapeutics
• Nkarta Therapeutics
• Fortress Biotech
• Nkure

第8章 ナチュラルキラー細胞療法 市場動向

• ナチュラルキラー細胞療法 業界動向
• ナチュラルキラー細胞療法 市場の促進要因
• ナチュラルキラー細胞療法 市場の課題
• ナチュラルキラー細胞療法 市場の抑制要因

第9章 市場調査結果と結論

第10章 付録

List of Tables

Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Natural Killer Cell Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Natural Killer Cell Therapy Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Natural Killer Cell Therapy Revenue Share by Region (2020-2025)

Table 6. Global Natural Killer Cell Therapy Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Natural Killer Cell Therapy Revenue Share Forecast by Region (2026-2031)

Table 8. Global Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)

Table 10. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Natural Killer Cell Therapy Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)

Table 15. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Natural Killer Cell Therapy Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Natural Killer Cell Therapy Application

Table 18. Global Natural Killer Cell Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Natural Killer Cell Therapy Market Share by Players (2020-2025)

Table 20. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)

Table 21. Ranking of Global Top Natural Killer Cell Therapy Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Natural Killer Cell Therapy, Headquarters and Area Served

Table 24. Global Key Players of Natural Killer Cell Therapy, Product and Application

Table 25. Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Natural Killer Cell Therapy Revenue Market Share by Company (2020-2025)

Table 29. North America Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Natural Killer Cell Therapy Revenue Market Share by Company (2020-2025)

Table 33. Europe Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Natural Killer Cell Therapy Revenue Market Share by Company (2020-2025)

Table 37. China Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Natural Killer Cell Therapy Revenue Market Share by Company (2020-2025)

Table 41. Japan Natural Killer Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Natural Killer Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 43. Nektar Therapeutics Company Details

Table 44. Nektar Therapeutics Business Overview

Table 45. Nektar Therapeutics Natural Killer Cell Therapy Product

Table 46. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 47. Nektar Therapeutics Recent Development

Table 48. ImmunityBio, Inc Company Details

Table 49. ImmunityBio, Inc Business Overview

Table 50. ImmunityBio, Inc Natural Killer Cell Therapy Product

Table 51. ImmunityBio, Inc Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 52. ImmunityBio, Inc Recent Development

Table 53. GC Cell Company Details

Table 54. GC Cell Business Overview

Table 55. GC Cell Natural Killer Cell Therapy Product

Table 56. GC Cell Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 57. GC Cell Recent Development

Table 58. Affimed Company Details

Table 59. Affimed Business Overview

Table 60. Affimed Natural Killer Cell Therapy Product

Table 61. Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 62. Affimed Recent Development

Table 63. Innate Pharma SA Company Details

Table 64. Innate Pharma SA Business Overview

Table 65. Innate Pharma SA Natural Killer Cell Therapy Product

Table 66. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 67. Innate Pharma SA Recent Development

Table 68. Fate Therapeutics Company Details

Table 69. Fate Therapeutics Business Overview

Table 70. Fate Therapeutics Natural Killer Cell Therapy Product

Table 71. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 72. Fate Therapeutics Recent Development

Table 73. Glycostem Therapeutics Company Details

Table 74. Glycostem Therapeutics Business Overview

Table 75. Glycostem Therapeutics Natural Killer Cell Therapy Product

Table 76. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 77. Glycostem Therapeutics Recent Development

Table 78. Dragonfly Therapeutics Company Details

Table 79. Dragonfly Therapeutics Business Overview

Table 80. Dragonfly Therapeutics Natural Killer Cell Therapy Product

Table 81. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 82. Dragonfly Therapeutics Recent Development

Table 83. Nkarta Therapeutics Company Details

Table 84. Nkarta Therapeutics Business Overview

Table 85. Nkarta Therapeutics Natural Killer Cell Therapy Product

Table 86. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 87. Nkarta Therapeutics Recent Development

Table 88. Fortress Biotech Company Details

Table 89. Fortress Biotech Business Overview

Table 90. Fortress Biotech Natural Killer Cell Therapy Product

Table 91. Fortress Biotech Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 92. Fortress Biotech Recent Development

Table 93. Nkure Company Details

Table 94. Nkure Business Overview

Table 95. Nkure Natural Killer Cell Therapy Product

Table 96. Nkure Revenue in Natural Killer Cell Therapy Business (2020-2025) & (US$ Million)

Table 97. Nkure Recent Development

Table 98. Natural Killer Cell Therapy Market Trends

Table 99. Natural Killer Cell Therapy Market Drivers

Table 100. Natural Killer Cell Therapy Market Challenges

Table 101. Natural Killer Cell Therapy Market Restraints

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Natural Killer Cell Therapy Product Picture

Figure 2. Global Natural Killer Cell Therapy Market Share by Type: 2024 VS 2031

Figure 3. NK Cell Therapy Features

Figure 4. CAR-NK Cell Therapy Features

Figure 5. Global Natural Killer Cell Therapy Market Share by Application: 2024 VS 2031

Figure 6. Cancer

Figure 7. Infectious Diseases

Figure 8. Gastrointestinal Diseases

Figure 9. Beauty and Anti-Aging

Figure 10. Others

Figure 11. Natural Killer Cell Therapy Report Years Considered

Figure 12. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Natural Killer Cell Therapy Revenue Market Share by Region: 2020 VS 2024

Figure 15. North America Natural Killer Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Europe Natural Killer Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. China Natural Killer Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Japan Natural Killer Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Global Natural Killer Cell Therapy Market Share by Players in 2024

Figure 20. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2024

Figure 22. North America Natural Killer Cell Therapy Market Share by Type (2020-2025)

Figure 23. North America Natural Killer Cell Therapy Market Share by Application (2020-2025)

Figure 24. Europe Natural Killer Cell Therapy Market Share by Type (2020-2025)

Figure 25. Europe Natural Killer Cell Therapy Market Share by Application (2020-2025)

Figure 26. China Natural Killer Cell Therapy Market Share by Type (2020-2025)

Figure 27. China Natural Killer Cell Therapy Market Share by Application (2020-2025)

Figure 28. Japan Natural Killer Cell Therapy Market Share by Type (2020-2025)

Figure 29. Japan Natural Killer Cell Therapy Market Share by Application (2020-2025)

Figure 30. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 31. ImmunityBio, Inc Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 32. GC Cell Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 33. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 34. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 35. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 36. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 37. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 38. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 39. Fortress Biotech Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 40. Nkure Revenue Growth Rate in Natural Killer Cell Therapy Business (2020-2025)

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

This research report focuses on the Natural Killer Cell Therapy Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market by Type
  • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
  • 1.2.2 NK Cell Therapy
  • 1.2.3 CAR-NK Cell Therapy
• 1.3 Market by Application
  • 1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Cancer
  • 1.3.3 Infectious Diseases
  • 1.3.4 Gastrointestinal Diseases
  • 1.3.5 Beauty and Anti-Aging
  • 1.3.6 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Natural Killer Cell Therapy Market Perspective (2020-2031)
• 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
• 2.3 Global Natural Killer Cell Therapy Revenue Market Share by Region (2020-2025)
• 2.4 Global Natural Killer Cell Therapy Revenue Forecast by Region (2026-2031)
• 2.5 Major Region and Emerging Market Analysis
  • 2.5.1 North America Natural Killer Cell Therapy Market Size and Prospective (2020-2031)
  • 2.5.2 Europe Natural Killer Cell Therapy Market Size and Prospective (2020-2031)
  • 2.5.3 China Natural Killer Cell Therapy Market Size and Prospective (2020-2031)
  • 2.5.4 Japan Natural Killer Cell Therapy Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

• 3.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2020-2025)
• 3.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2026-2031)
• 3.3 Different Types Natural Killer Cell Therapy Representative Players

4 Breakdown Data by Application

• 4.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2020-2025)
• 4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2026-2031)
• 4.3 New Sources of Growth in Natural Killer Cell Therapy Application

5 Competition Landscape by Players

• 5.1 Global Top Players by Revenue
  • 5.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2020-2025)
  • 5.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2020-2025)
• 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 5.3 Players Covered: Ranking by Natural Killer Cell Therapy Revenue
• 5.4 Global Natural Killer Cell Therapy Market Concentration Analysis
  • 5.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 5.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2024
• 5.5 Global Key Players of Natural Killer Cell Therapy Head office and Area Served
• 5.6 Global Key Players of Natural Killer Cell Therapy, Product and Application
• 5.7 Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry
• 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments and Downstream
  • 6.1.1 North America Natural Killer Cell Therapy Revenue by Company (2020-2025)
  • 6.1.2 North America Market Size by Type
    • 6.1.2.1 North America Natural Killer Cell Therapy Market Size by Type (2020-2025)
    • 6.1.2.2 North America Natural Killer Cell Therapy Market Share by Type (2020-2025)
  • 6.1.3 North America Market Size by Application
    • 6.1.3.1 North America Natural Killer Cell Therapy Market Size by Application (2020-2025)
    • 6.1.3.2 North America Natural Killer Cell Therapy Market Share by Application (2020-2025)
  • 6.1.4 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments and Downstream
  • 6.2.1 Europe Natural Killer Cell Therapy Revenue by Company (2020-2025)
  • 6.2.2 Europe Market Size by Type
    • 6.2.2.1 Europe Natural Killer Cell Therapy Market Size by Type (2020-2025)
    • 6.2.2.2 Europe Natural Killer Cell Therapy Market Share by Type (2020-2025)
  • 6.2.3 Europe Market Size by Application
    • 6.2.3.1 Europe Natural Killer Cell Therapy Market Size by Application (2020-2025)
    • 6.2.3.2 Europe Natural Killer Cell Therapy Market Share by Application (2020-2025)
  • 6.2.4 Europe Market Trend and Opportunities
• 6.3 China Market: Players, Segments and Downstream
  • 6.3.1 China Natural Killer Cell Therapy Revenue by Company (2020-2025)
  • 6.3.2 China Market Size by Type
    • 6.3.2.1 China Natural Killer Cell Therapy Market Size by Type (2020-2025)
    • 6.3.2.2 China Natural Killer Cell Therapy Market Share by Type (2020-2025)
  • 6.3.3 China Market Size by Application
    • 6.3.3.1 China Natural Killer Cell Therapy Market Size by Application (2020-2025)
    • 6.3.3.2 China Natural Killer Cell Therapy Market Share by Application (2020-2025)
  • 6.3.4 China Market Trend and Opportunities
• 6.4 Japan Market: Players, Segments and Downstream
  • 6.4.1 Japan Natural Killer Cell Therapy Revenue by Company (2020-2025)
  • 6.4.2 Japan Market Size by Type
    • 6.4.2.1 Japan Natural Killer Cell Therapy Market Size by Type (2020-2025)
    • 6.4.2.2 Japan Natural Killer Cell Therapy Market Share by Type (2020-2025)
  • 6.4.3 Japan Market Size by Application
    • 6.4.3.1 Japan Natural Killer Cell Therapy Market Size by Application (2020-2025)
    • 6.4.3.2 Japan Natural Killer Cell Therapy Market Share by Application (2020-2025)
  • 6.4.4 Japan Market Trend and Opportunities

7 Key Players Profiles

• 7.1 Nektar Therapeutics
  • 7.1.1 Nektar Therapeutics Company Details
  • 7.1.2 Nektar Therapeutics Business Overview
  • 7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
  • 7.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.1.5 Nektar Therapeutics Recent Development
• 7.2 ImmunityBio, Inc
  • 7.2.1 ImmunityBio, Inc Company Details
  • 7.2.2 ImmunityBio, Inc Business Overview
  • 7.2.3 ImmunityBio, Inc Natural Killer Cell Therapy Introduction
  • 7.2.4 ImmunityBio, Inc Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.2.5 ImmunityBio, Inc Recent Development
• 7.3 GC Cell
  • 7.3.1 GC Cell Company Details
  • 7.3.2 GC Cell Business Overview
  • 7.3.3 GC Cell Natural Killer Cell Therapy Introduction
  • 7.3.4 GC Cell Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.3.5 GC Cell Recent Development
• 7.4 Affimed
  • 7.4.1 Affimed Company Details
  • 7.4.2 Affimed Business Overview
  • 7.4.3 Affimed Natural Killer Cell Therapy Introduction
  • 7.4.4 Affimed Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.4.5 Affimed Recent Development
• 7.5 Innate Pharma SA
  • 7.5.1 Innate Pharma SA Company Details
  • 7.5.2 Innate Pharma SA Business Overview
  • 7.5.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
  • 7.5.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.5.5 Innate Pharma SA Recent Development
• 7.6 Fate Therapeutics
  • 7.6.1 Fate Therapeutics Company Details
  • 7.6.2 Fate Therapeutics Business Overview
  • 7.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
  • 7.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.6.5 Fate Therapeutics Recent Development
• 7.7 Glycostem Therapeutics
  • 7.7.1 Glycostem Therapeutics Company Details
  • 7.7.2 Glycostem Therapeutics Business Overview
  • 7.7.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
  • 7.7.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.7.5 Glycostem Therapeutics Recent Development
• 7.8 Dragonfly Therapeutics
  • 7.8.1 Dragonfly Therapeutics Company Details
  • 7.8.2 Dragonfly Therapeutics Business Overview
  • 7.8.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
  • 7.8.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.8.5 Dragonfly Therapeutics Recent Development
• 7.9 Nkarta Therapeutics
  • 7.9.1 Nkarta Therapeutics Company Details
  • 7.9.2 Nkarta Therapeutics Business Overview
  • 7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
  • 7.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.9.5 Nkarta Therapeutics Recent Development
• 7.10 Fortress Biotech
  • 7.10.1 Fortress Biotech Company Details
  • 7.10.2 Fortress Biotech Business Overview
  • 7.10.3 Fortress Biotech Natural Killer Cell Therapy Introduction
  • 7.10.4 Fortress Biotech Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.10.5 Fortress Biotech Recent Development
• 7.11 Nkure
  • 7.11.1 Nkure Company Details
  • 7.11.2 Nkure Business Overview
  • 7.11.3 Nkure Natural Killer Cell Therapy Introduction
  • 7.11.4 Nkure Revenue in Natural Killer Cell Therapy Business (2020-2025)
  • 7.11.5 Nkure Recent Development

8 Natural Killer Cell Therapy Market Dynamics

• 8.1 Natural Killer Cell Therapy Industry Trends
• 8.2 Natural Killer Cell Therapy Market Drivers
• 8.3 Natural Killer Cell Therapy Market Challenges
• 8.4 Natural Killer Cell Therapy Market Restraints

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer